Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionFranklin Resources Inc
Latest Disclosed Ownership400,917 shares
Latest Disclosed Value $ 22,595,678
Franklin Resources Inc reports 13.61% decrease in ownership of HAE / Haemonetics Corporation

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 400,917 shares of Haemonetics Corporation (US:HAE) valued at $22,595,682 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 464,104 shares of Haemonetics Corporation. This represents a change in shares of -13.61% during the quarter. The current value of the position is $26,412,412 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 400,917 -63,187 -13.61 22,596 -39.26 0.0009
2026-02-11 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 464,104 -163,127 -26.01 37,198 21.67 0.0091
2025-11-13 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 627,231 12,005 1.95 30,571 -33.40 0.0076
2025-08-12 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 615,226 60,582 10.92 45,902 30.23 0.0122
2025-05-13 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 554,644 6,680 1.22 35,248 -17.62 0.0101
2025-02-12 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 547,964 -134,084 -19.66 42,785 -16.68 0.0119
2024-11-27 2024-09-30 13F/A-1 HAEMONETICS CORP MASS COM 405024100 682,048 -742,629 -52.13 51,351 -56.43 0.0144
2024-11-12 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 682,048 -742,629 51,351 0.0025
2024-08-14 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,424,677 31,034 2.23 117,864 -0.91 0.0362
2024-05-13 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,393,643 -300,237 -17.72 118,947 -17.88 0.0377
2024-02-09 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,693,880 -505 -0.03 144,844 -4.57 0.0677
2023-11-13 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 1,694,385 55,947 3.41 151,783 8.81 0.0771
2023-08-11 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,638,438 222,943 15.75 139,497 19.09 0.0663
2023-05-12 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,415,495 63,787 4.72 117,132 10.18 0.0588
2023-02-10 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,351,708 1,041 0.08 106,312 6.32 0.0553
2022-11-14 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 1,350,667 47,254 3.63 99,989 17.70 0.0545
2022-08-11 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,303,413 -167,834 -11.41 84,956 -8.66 0.0421
2022-05-13 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,471,247 3,677 0.25 93,013 19.49 0.0372
2022-02-11 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,467,570 -12,318 -0.83 77,840 -25.49 0.0281
2021-11-12 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 1,479,888 138,399 10.32 104,466 16.86 0.0393
2021-08-13 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,341,489 -521,221 -27.98 89,397 -56.77 0.0342
2021-05-13 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,862,710 66,619 3.71 206,780 -3.05 0.0841
2021-02-10 2020-12-31 13F HAEMONETICS COM 405024100 1,796,091 72,240 4.19 213,286 41.81 0.0903
2020-11-12 2020-09-30 13F HAEMONETICS COM 405024100 1,723,851 438,864 34.15 150,407 27.17 0.0728
2020-08-13 2020-06-30 13F HAEMONETICS COM 405024100 1,284,987 261,830 25.59 118,271 15.99 0.0609
2020-05-13 2020-03-31 13F HAEMONETICS COM 405024100 1,023,157 -123 -0.01 101,967 -13.27 0.0681
2020-03-11 2019-12-31 13F/A-1 HAEMONETICS COM 405024100 1,023,280 -3,190 -0.31 117,575 -9.19 0.0618
2020-02-12 2019-12-31 13F HAEMONETICS COM 405024100 1,023,280 -3,190 117,575 14,851.3322
2019-11-14 2019-09-30 13F HAEMONETICS COM 405024100 1,026,470 4,635 0.45 129,478 5.29 0.0703
2019-08-14 2019-06-30 13F HAEMONETICS COM 405024100 1,021,835 18,341 1.83 122,967 40.08 0.0654
2019-05-15 2019-03-31 13F/A-1 HAEMONETICS COM 405024100 1,003,494 554 0.06 87,785 -12.52 0.0470
2019-05-14 2019-03-31 13F HAEMONETICS COM 405024100 1,003,494 554 87,785
2019-02-12 2018-12-31 13F HAEMONETICS COM 405024100 1,002,940 184 0.02 100,344 -12.67 0.0606
2018-11-13 2018-09-30 13F HAEMONETICS COM 405024100 1,002,756 831 0.08 114,896 27.87 0.0572
2018-08-14 2018-06-30 13F HAEMONETICS COM 405024100 1,001,925 1,925 0.19 89,853 22.82 0.0461
2018-05-10 2018-03-31 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 73,160 25.96 0.0371
2018-02-14 2017-12-31 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 58,080 29.44 0.0279
2017-11-13 2017-09-30 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 44,870 13.62 0.0220
2017-08-10 2017-06-30 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 39,490 -2.66 0.0197
2017-05-12 2017-03-31 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 40,570 0.92 0.0206
2017-02-14 2016-12-31 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 40,200 11.02 0.0208
2016-11-14 2016-09-30 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 36,210 24.91 0.0189
2016-08-11 2016-06-30 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 28,990 -17.12 0.0156
2016-05-10 2016-03-31 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 34,980 8.50 0.0186
2016-04-27 2015-12-31 13F/A-1 HAEMONETICS COM 405024100 1,000,000 0 0.00 32,240 -0.25 0.0163
2016-02-12 2015-12-31 13F HAEMONETICS COM 405024100 1,000,000 32,240
2015-11-10 2015-09-30 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 32,320 -21.86 0.0160
2015-08-12 2015-06-30 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 41,360 -7.93 0.0188
2015-05-14 2015-03-31 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 44,920 20.04 0.0204
2015-02-10 2014-12-31 13F HAEMONETICS COM 405024100 1,000,000 -22 -0.00 37,420 7.16 0.0170
2014-11-12 2014-09-30 13F HAEMONETICS COM 405024100 1,000,022 22 0.00 34,921 -1.02 0.0159
2014-08-12 2014-06-30 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 35,280 8.25 0.0155
2014-05-13 2014-03-31 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 32,590 -22.64 0.0154
2014-02-12 2013-12-31 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 42,130 5.64 0.0206
2013-11-14 2013-09-30 13F HAEMONETICS COM 405024100 1,000,000 0 0.00 39,880 -3.56 0.0212
2013-08-09 2013-06-30 13F HAEMONETICS COM 405024100 1,000,000 1,000,000 41,350 0.0236
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.